康宁杰瑞制药-B:2025中期报告

香港交易所
Sep 26

牛牛AI助手已提取核心信息康宁杰瑞生物制药于2025年上半年实现营业收入3.19亿元人民币,同比增长84%;毛利2.88亿元,毛利率90.2%;期内实现净利润2,158万元,相比去年同期亏损4,490万元实现扭亏为盈。收入增长主要来自许可费收入增加至2.46亿元及药品销售收入6,702万元。公司研发投入持续加大,研发费用同比增长30%至2.53亿元。期内多个在研产品取得重要进展:KN026的II/...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10